3-Acetyl-4-hydroxy-2H-chromen-2-one

Catalog No. :
ACIFNH095
CAS No. :
2555-37-5
Molecular Formula :
C11H8O4
Molecular Weight :
204.18

IUPAC Name:3-acetyl-4-hydroxy-2H-chromen-2-one

3-Acetyl-4-hydroxy-2H-chromen-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$110.00Login to see priceIn stockInquiry
5g95%$339.00Login to see priceIn stockInquiry
25g95%$1342.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Acetyl-4-hydroxy-2H-chromen-2-one
IUPAC Name3-acetyl-4-hydroxy-2H-chromen-2-one
MDL No.MFCD00138133
Molecular FormulaC11H8O4
Molecular Weight204.18
SMILESO=C1C(C(C)=O)=C(O)C2=C(O1)C=CC=C2
InChI KeyUTZHUXAPJIBIBQ-UHFFFAOYSA-N
Synonym3-acetyl-4-hydroxy-2-benzopyrone;3-ACETYL-4-HYDROXY-2H-1-BENZOPYRAN-2-ONE;2H-1-benzopyran-2-one, 3-acetyl-4-hydroxy-;3-acetyl-2-hydroxychromen-4-one;3-acetyl-2-hydroxy-chromone;3-ethanoyl-2-hydroxy-chromen-4-one;3-acetyl-4-hydroxychromen-2-one
CAS No.2555-37-5
PubChem CID54677403

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACIFNH095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACMYDN516 route compound structure diagram
    ACMYDN5161076-38-6 In Stock
  6. Then
  7. ACIFNH095 route product structure diagram
    ACIFNH0952555-37-5 In Stock
Inquiry

2. ACIFNH095 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIFNH095 route product structure diagram
    ACIFNH0952555-37-5 In Stock
Inquiry

Comments (0)